pyrroles has been researched along with Osteoporosis in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (57.14) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, Z; Mai, X; Qin, X; Song, F; Wang, N; Xie, W | 1 |
| Burkhart, C; Haberhauer, G; Heusch, G; Keul, P; Levkau, B; Manthe, K; Vaidya, M; von Wnuck Lipinski, K; Weske, S | 1 |
| Ge, XT; Guo, JX; Li, CL; Li, TY; Lv, F; Wang, XF; Wang, YJ | 1 |
| Abad, L; de Luis, D; Duenas-Laita, A; Gonzalez Sagredo, M; Pérez-Castrillón, JL; Sanz-Cantalapiedra, A; Vega, G | 1 |
| Abad, L; De Luis, D; Duenas-Laita, A; Pérez-Castrillón, JL; Sagredo, MG; Sanz-Cantalapiedra, A; Vega, G | 1 |
| Baytur, Y; Demir, BC; Gumuser, G; Inceboz, U; Ozbilgin, K; Uyar, Y | 1 |
| Furuya, K | 1 |
| Masuya, K; Teno, N | 1 |
| Gradosova, I; Hubena, S; Palicka, V; Svejkovska, K; Zivna, H; Zivny, P | 1 |
| Altmann, E; Missbach, M; Widler, L | 1 |
| Carmina, E; Castello, F; Di Fede, G; Mansueto, P; Rini, GB; Rizzo, M | 1 |
| Jadhav, SB; Jain, GK | 1 |
| Bielinska, A; Gluszko, P | 1 |
| Bhargava, A; Bombara, M; Caringal, Y; Dally, R; Dumas, J; Gunn, D; Housley, TJ; Johnson, JS; Kingery-Wood, J; Lee, W; Osterhout, M; Paulsen, H; Ranges, GE; Redman, AM; Renick, J; Scott, WJ; Shrikhande, A; Smith, RA; Swartz, S; Wild, H; Wilhelm, SM; Young, D | 1 |
6 review(s) available for pyrroles and Osteoporosis
| Article | Year |
|---|---|
[Bone and Men's Health. Bone selective androgen receptor modulators].
Topics: Acetamides; Amides; Aminophenols; Androgens; Anilides; Animals; Drug Design; Female; Humans; Male; Osteogenesis; Osteoporosis; Pyrroles; Pyrrolidines; Quinolones; Receptors, Androgen | 2010 |
Orally bioavailable cathepsin K inhibitors with pyrrolopyrimidine scaffold.
Topics: Administration, Oral; Animals; Biological Availability; Bone Resorption; Cathepsin K; Cysteine Proteinase Inhibitors; Humans; Osteoporosis; Pyrimidines; Pyrroles; Structure-Activity Relationship | 2010 |
N(7)-substituted-5-aryl-pyrrolo[2,3-d]pyrimidines represent a versatile class of potent inhibitors of the tyrosine kinase c-Src.
Topics: Animals; CSK Tyrosine-Protein Kinase; Humans; Inhibitory Concentration 50; Osteoporosis; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; src-Family Kinases; Structure-Activity Relationship | 2002 |
Statins and osteoporosis: myth or reality?
Topics: Anticholesteremic Agents; Atorvastatin; Bone Development; Female; Fractures, Bone; Heptanoic Acids; Humans; Osteoporosis; Pyrroles; Simvastatin | 2004 |
Statins and osteoporosis: new role for old drugs.
Topics: Animals; Atorvastatin; Bone and Bones; Clinical Trials as Topic; Drug Delivery Systems; Fatty Acids, Monounsaturated; Fluorobenzenes; Fluvastatin; Fractures, Bone; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Liver; Lovastatin; Osteogenesis; Osteoporosis; Pharmacokinetics; Pravastatin; Pyridines; Pyrimidines; Pyrroles; Quinolines; Rosuvastatin Calcium; Simvastatin; Sulfonamides | 2006 |
[Statins--are they potentially useful in rheumatology?].
Topics: Arthritis, Rheumatoid; Atorvastatin; Heptanoic Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lupus Erythematosus, Systemic; Osteoporosis; Pyrroles; Rheumatic Diseases; Simvastatin; Treatment Outcome | 2007 |
8 other study(ies) available for pyrroles and Osteoporosis
| Article | Year |
|---|---|
Oxygen Plasma Technology-Assisted Preparation of Three-Dimensional Reduced Graphene Oxide/Polypyrrole/Strontium Composite Scaffold for Repair of Bone Defects Caused by Osteoporosis.
Topics: Animals; Biocompatible Materials; Cell Line; Graphite; Mice; Osteoblasts; Osteoporosis; Polymers; Printing, Three-Dimensional; Pyrroles; Strontium; Tissue Engineering; Tissue Scaffolds | 2021 |
Agonist-induced activation of the S1P receptor 2 constitutes a novel osteoanabolic therapy for the treatment of osteoporosis in mice.
Topics: Anabolic Agents; Animals; Female; Mice; Mice, Inbred C57BL; Osteoporosis; Ovariectomy; Pyrroles; Sphingosine-1-Phosphate Receptors | 2019 |
Colony-stimulating factor 1 receptor inhibition prevents against lipopolysaccharide -induced osteoporosis by inhibiting osteoclast formation.
Topics: Aminopyridines; Animals; Biomechanical Phenomena; Bone Density; Bone Resorption; Cancellous Bone; Disease Models, Animal; Lipopolysaccharides; Male; Osteoclasts; Osteoporosis; Pyrroles; Rats, Sprague-Dawley; Receptor, Macrophage Colony-Stimulating Factor; Tibia | 2019 |
Effect of the TNFalpha-308 G/A polymorphism on the changes produced by atorvastatin in bone mineral density in patients with acute coronary syndrome.
Topics: Absorptiometry, Photon; Acute Coronary Syndrome; Amino Acids; Anticholesteremic Agents; Atorvastatin; Bone Density; Calcium; Cholesterol; Dose-Response Relationship, Drug; Female; Femur Neck; Follow-Up Studies; Genotype; Heptanoic Acids; Humans; Magnesium; Male; Middle Aged; Osteocalcin; Osteoporosis; Phosphorus; Polymerase Chain Reaction; Polymorphism, Genetic; Pyrroles; Risk Factors; Triglycerides; Tumor Necrosis Factor-alpha | 2008 |
Atorvastatin and BMD in coronary syndrome. Role of Lys656Asn polymorphism of leptin receptor gene.
Topics: Acute Coronary Syndrome; Aged; Atorvastatin; Bone Density; Bone Remodeling; Female; Heptanoic Acids; Humans; Male; Middle Aged; Osteoporosis; Polymorphism, Genetic; Pyrroles; Receptors, Leptin | 2009 |
Comparative effects of risedronate, atorvastatin, estrogen and SERMs on bone mass and strength in ovariectomized rats.
Topics: Animals; Anticholesteremic Agents; Atorvastatin; Bone Density; Bone Density Conservation Agents; Clomiphene; Estrogens; Etidronic Acid; Female; Femur; Heptanoic Acids; Osteoporosis; Ovariectomy; Pyrroles; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Risedronic Acid; Selective Estrogen Receptor Modulators; Tibia | 2009 |
Protective effect of atorvastatin on bone tissue in orchidectomised male albino Wistar rats.
Topics: Animals; Atorvastatin; Biomarkers; Bone and Bones; Bone Density; Bone Density Conservation Agents; Calcium; Compressive Strength; Disease Models, Animal; Femur; Heptanoic Acids; Male; Orchiectomy; Osteoporosis; Pyrroles; Rats; Rats, Wistar; Tibia | 2012 |
p38 kinase inhibitors for the treatment of arthritis and osteoporosis: thienyl, furyl, and pyrrolyl ureas.
Topics: Arthritis; Enzyme Inhibitors; Furans; Humans; Inhibitory Concentration 50; Interleukin-6; Mitogen-Activated Protein Kinases; Molecular Structure; Osteoporosis; p38 Mitogen-Activated Protein Kinases; Pyrroles; Thiophenes; Tumor Cells, Cultured; Urea | 2001 |